LEFT VENTRICULAR NON-COMPACTION AS DIAGNOSED BY ESTABLISHED CARDIAC MAGNETIC RESONANCE IMAGING CRITERIA IS NOT ASSOCIATED WITH INCREASED ADVERSE EVENTS COMPARED TO NON-ISCHEMIC DILATED CARDIOMYOPATHY

The incidence of prior stroke, diabetes mellitus, hypertension, end-stage renal disease and cancer did not differ between the groups. Mean Age 50.9 +/- 17.9 50.4 +/- 15.3 0.907 Stroke 1 (5.6) 1 (1.9) 0.416 Diabetes Mellitus 4 (22.2) 16 (30.2) 0.516 Hypertension 9 (50) 27 (50.9) 0.945 End-Stage Renal Disease 0 (0) 1 (1.9) 0.557 Cancer 3 (16.7) 7 (13.2) 0.715 Average Number of Heart Failure Admissions per Patient 0.83 +/- 1.0 0.73 +/- 1.2 0.747 Thromboembolic Events 2 (11) 3 (5.7) 0.435 Supraventricular Tachycardia 6 (33.3) 10 (18.9) 0.204 Ventricular Tachycardia 2 (11.1) 11 (20.8) 0.473 Left Ventricular Assist Device 1 (5.6) 0 (0) 0.084 ICD 6 (33.3) 10 (18.9) 0.393 Heart Transplantation 0 (0) 0 (0) - Mortality 0 (0) 1 (1.9) 0.557 LV EF (%) 36.0 +/- 17.9 36.1 +/- 12.7 0.992 LV End Diastolic Volume Index (mL/m2) 139.0 +/- 49.0 122.0 +/- 41.4 0.157 LV End Systolic Volume Index (mL/m2) 93.8 +/- 53.6 81.9 +/- 41.6 0.333 LV Mass Index (g/m2) 58.9 +/- 19.5 65.0 +/- 20.8 0.277 RV EF (%) 45.4 +/- 12.4 46.1 +/- 10.3 0.816 RV End Diastolic Volume Index (mL/m2) 88.3 +/- 24.3 84.8 +/- 27.7 0.634 RV End Systolic Volume index (mL/m2) 47.6 +/- 22.6 47.1 +/- 22.5 0.927 LA Volume Index (mL/m2) 64.6 +/- 18.7 54.8 +/- 23.9 0.122 Data displayed as n (%) or mean +/- standard deviation.